Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial

NCT00822926 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DRUG: Botulinum Toxin Type A
DRUG: Saline

Sponsor

Stanford University